US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

55.51

-0.1900-0.34%

Volume:946

Turnover:52.52K

Market Cap:189.84M

PE:- -

High:55.51

Open:55.51

Low:55.48

Close:55.70

52wk High:56.45

52wk Low:39.08

Shares:3.42M

Float Shares:3.42M

Volume Ratio:2.23

T/O Rate:0.03%

Dividend:0.00

Dividend Rate:0.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate

Benzinga Earnings

Brightspring Health Services Q2 Net Income USD 87 Million

THOMSON REUTERS

Brightspring Health Services - Sees Fy2026 Revenue $15.10 Bln-$15.43 Bln, up 17%-19.5%

THOMSON REUTERS

Brightspring Health Services Inc Fy2026 REV View $15.06 Bln

THOMSON REUTERS

Brightspring Health Services - Sees Fy2026 Adj Ebitda $820 Mln-$845 Mln, up 32.8%-36.8%

THOMSON REUTERS

Brightspring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

THOMSON REUTERS

BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Disc Medicine Posts Smaller-than-expected Q2 Net Loss

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $161 from $150

THOMSON REUTERS

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Benzinga Earnings

Corcept Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Corcept Therapeutics Q2 EPS USD 0.36

Corcept Q2 FY26 Net Income Rises to $43 Million; Revenue Climbs 32% to $256.1 Million

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says

MT Newswires Live

Viatris receives FDA approval for Gwyn Lo contraceptive patch

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $150 from $135

THOMSON REUTERS

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PSCH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":55.51,"timestamp":1787751342561,"preClose":55.7,"halted":0,"volume":946,"delay":0,"changeRate":-0.0034111310592460473,"floatShares":3420000,"shares":3420000,"eps":0,"marketStatus":"Trading","change":-0.19,"latestTime":"08-26 09:37:35 EDT","open":55.5076,"high":55.51,"low":55.4825,"amount":52516.918498,"amplitude":0.000494,"askPrice":55.65,"askSize":400,"bidPrice":55.29,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":55.7,"sharesOutstanding":3220000,"nav":55.44727,"aum":189075190.7,"dividendRate":0.000054,"bidAskSpread":0.001784,"preHourTrading":{"tag":"盘前","latestPrice":54.57,"preClose":55.7,"latestTime":"07:00 EDT","volume":53,"amount":2892.21,"timestamp":1787742014879,"change":-1.13,"changeRate":-0.020287,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":55.7,"preClose":55.7,"latestTime":"19:30 EDT","volume":12,"amount":666.72,"timestamp":1787700602218,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.234137,"impliedVol":0.1092,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3420000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.234137,"shares":3420000,"dividePrice":0.003,"high":55.51,"amplitude":0.000494,"preClose":55.7,"low":55.4825,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":55.51,"committee":0.111111,"eps":0,"divideRate":0.000054,"volume":946,"delay":0,"ttmEps":0,"open":55.5076,"prevYearClose":44.0553,"prevWeekClose":55.6522,"prevMonthClose":53.39,"prevQuarterClose":52.3666,"fiveDayClose":56.22,"twentyDayClose":53.2244,"sixtyDayClose":44.8324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655529043","title":"BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655529043","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655529043?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:01","pubTimestamp":1785492070,"startTime":"0","endTime":"0","summary":"BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60830358/brightspring-health-q2-adj-eps-0-45-beats-0-40-estimate-sales-3-873b-beat-3-658b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU2468319806.SGD","LU2089984988.USD","PTH","PSCH","LU2324357040.USD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655352982","title":"Brightspring Health Services Q2 Net Income USD 87 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655352982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655352982?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nPLX52K4SS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU2324357040.USD","BK4196","BTSG","PTH","PSCH","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655352719","title":"Brightspring Health Services - Sees Fy2026 Revenue $15.10 Bln-$15.43 Bln, up 17%-19.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655352719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655352719?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nPLX52K4SS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","LU2468319806.SGD","LU2324357040.USD","BK4196","PTH","BTSG","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655048352","title":"Brightspring Health Services Inc Fy2026 REV View $15.06 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655048352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655048352?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nPLX52K4SS:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4196","BTSG","LU2468319806.SGD","LU2089984988.USD","LU2324357040.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655012352","title":"Brightspring Health Services - Sees Fy2026 Adj Ebitda $820 Mln-$845 Mln, up 32.8%-36.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655012352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655012352?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nPLX52K4SS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","PTH","LU2089984988.USD","PSCH","BTSG","LU2324357040.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655352954","title":"Brightspring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2655352954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655352954?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nTUA69JSZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","LU2468319806.SGD","LU2324357040.USD","BTSG","PSCH","LU2089984988.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655059352","title":"BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2655059352","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655059352?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492000,"startTime":"0","endTime":"0","summary":"LOUISVILLE, Ky., July  31, 2026  (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/31/3336665/0/en/BrightSpring-Health-Services-Inc-Reports-Second-Quarter-2026-Financial-Results-and-Increases-Full-Year-2026-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4196","LU2089984988.USD","PSCH","LU2468319806.SGD","LU2324357040.USD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655287772","title":"Disc Medicine Posts Smaller-than-expected Q2 Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2655287772","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655287772?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:39","pubTimestamp":1785415190,"startTime":"0","endTime":"0","summary":"Disc Medicine posts smaller-than-expected Q2 net lossOverviewUS biopharma firm's Q2 net loss and operating income both beat analyst expectationsQ2 loss per share was better than expectedOperating expe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","FBT","PSCH","CORT","LU0566484027.USD","BK4007","AVXL","LU1559883803.SGD","IRON","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655987926","title":"Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2655987926","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655987926?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:18","pubTimestamp":1785410307,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growthOverviewUS biopharma firm's Q2 revenue rose 88% yr/yr, beating analyst expectationsQ2 operating expenses fell 33% yr/yr due to l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W0KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4532","BK4139","BK4007","PBE","PHAT","IE00B19Z9P08.USD","LU0889565916.HKD","CORT","LU0566484027.USD","PSCH","LU0234570918.USD","BK4533","IE00B19Z9Z06.USD","BIIB","BMED","FBT","IE00B894F039.SGD","LU1559883803.SGD","LU0320765992.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655282910","title":"Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $161 from $150","url":"https://stock-news.laohu8.com/highlight/detail?id=2655282910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655282910?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:55","pubTimestamp":1785398154,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W1F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU1559883803.SGD","BK4007","CORT","FBT","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655782580","title":"Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2655782580","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655782580?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:48","pubTimestamp":1785394133,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics shares soared 21.95% after hours as strong quarterly results and raised guidance boosted investor confidence.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/07/60787510/corcept-therapeutics-shares-surge-after-hours-q2-results-raised-guidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","NUWE","ODDS","FBT","BETZ","CORT","BK4082","PSCH","LU1559883803.SGD","BK4007","ODDZ","RSI","BK4532","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655103338","title":"Corcept Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655103338","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655103338?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:40","pubTimestamp":1785364847,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCorcept Therapeutics IncCORT.OQreported quarterly adjusted earnings of 36 cents per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL8N43V3R6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","CORT","BK4007","PSCH","FBT","LU0566484027.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816067","title":"Corcept Therapeutics Q2 EPS USD 0.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816067","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816067?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:16","pubTimestamp":1785356177,"startTime":"0","endTime":"0","summary":"Jul 29 (Reuters) - Corcept Therapeutics Q2 revenue USD 256.147 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 29-JUL-202615:42:50 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nRSD73tzLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","PSCH","BK4007","CORT","LU1559883803.SGD","FBT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655581677","title":"Corcept Q2 FY26 Net Income Rises to $43 Million; Revenue Climbs 32% to $256.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655581677","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655581677?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:15","pubTimestamp":1785356143,"startTime":"0","endTime":"0","summary":"Corcept Q2 FY26 net income rises to $43 million; revenue climbs 32% to $256.1 millionCorcept Q2 revenue rose 32% to USD 256.1 million, with Korlym and authorized generic at USD 208.6 million and Lifyo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL3dG2zq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","LU0566484027.USD","CORT","BK4007","FBT","BK4532","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655162788","title":"Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2655162788","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655162788?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:13","pubTimestamp":1785355980,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Q2 revenue estimates, raises 2026 outlookOverviewU.S. biopharma firm's Q2 revenue rose 32% yr/yr, beating analyst expectationsNet income for Q2 increased to $43.0 mln from $35.1 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL1N43V1C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0566484027.USD","IE00B19Z9P08.USD","LU0320765992.SGD","BK4550","IDNA","IE00B894F039.SGD","LU0109394709.USD","PSCH","CORT","BK4007","LU0234570918.USD","BK4532","BK4139","BMED","IE00B19Z9Z06.USD","PBE","FBT","LU1559883803.SGD","BIIB","INCY","BK4588","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655926538","title":"Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2655926538","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655926538?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:53","pubTimestamp":1785340439,"startTime":"0","endTime":"0","summary":"Alkermes'  base business supported the company's Q2 beat, while its orexin pipeline serves as a potential catalyst for future revenue growth, RBC Capital Markets said in a Tuesday note.The company reported a breakeven in Q2, compared with earnings of $0.52 per share a year earlier, and revenue of $496 million, up from $390.7 million. For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion.Alkermes' core business drove the quarter's revenue beat, with recent highlights like less generic threat for Vivitrol and expanded access for Lybalvi, RBC said. The quarter also said one-time benefits from patient mix favorability, Lumryz inventory and Consta manufacturing, the brokerage added.Looking forward, investor focus is shifting to the company's orexin pipeline expansion into other indications, which could help pave the way for Alkermes's revenue to exceed $5 billion, RBC noted.RBC has an outperform rating and $56 price target on Alkermes.Price: 48.40, Chang","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","IBRN","FBT","PSIL","BK4139","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655895830","title":"Viatris receives FDA approval for Gwyn Lo contraceptive patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655895830","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655895830?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:16","pubTimestamp":1785330964,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) announced that the FDA has approved Gwyn Lo, a new combined hormonal contraceptive patch with low-dose estrogen. The patch has demon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","IYH","TECB","BBP","VTRS","FRTY","IBB","IDNA","XLVX","BMED","LU1839511570.USD","PSCH","GDOC","TBXU","BK4583","BK4585","RSPH","SYNB","GNMX","LU2087621335.USD","LFSC","IEIH","BK4588","MRNY","MRNX","MEDI","PINK","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655856718","title":"Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $150 from $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2655856718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655856718?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:51","pubTimestamp":1785304262,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","BK4532","CORT","LU0566484027.USD","PSCH","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385647","title":"Alkermes Plc : Jefferies Raises Target Price to $72 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385647?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:45","pubTimestamp":1785303957,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBT","MEDX","PSIL","PSCH","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655855711","title":"Alkermes Plc : TD Cowen Raises Target Price to $58 from $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2655855711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655855711?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:22","pubTimestamp":1785302541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","IBRN","MEDX","ALKS","FBT","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}